Research and experimental development on natural sciences and engineering
Industry Group: Scientific research and development
405
Companies
20
New Filings
Latest Industry Filings
Live Feed| Company | Document | Date |
|---|---|---|
| Dec 30 | ||
| Dec 30 | ||
| Dec 30 | ||
| Dec 30 | ||
| Dec 30 | ||
| Dec 29 | ||
| Dec 27 | ||
| Dec 27 | ||
| Dec 27 | ||
| Dec 24 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 | ||
| Dec 23 |
Industry Constituents
Company
Country
1N
1N
Spain
2C
2C
2cureX AB
2CUREX
|
SE
$1.99M
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
$1.99M
Sweden
AB
AB
Abera Bioscience AB
ABERA
|
SE
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
AB
AB
ABION Inc.
203400
|
KR
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
AB
AB
ABL Bio Inc.
298380
|
KR
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
AB
AB
Abpro Holdings, Inc.
ABP
|
US
$12.85M
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
$12.85M
United States of America
AB
AB
Absci Corp
ABSI
|
US
$535.32M
A generative AI drug creation company developing biologic medicines.
$535.32M
United States of America
AC
AC
Achiko AG
ACHI
|
CH
A digital services platform for cross-border business compliance and engagement.
Switzerland
AC
AC
Active Biotech
ACTI
|
SE
$7.43M
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
$7.43M
Sweden
AD
AD
Adagene Inc.
ADAG
|
US
$84.84M
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
$84.84M
United States of America
AD
AD
Adaptive Biotechnologies Corp
ADPT
|
US
$2.60B
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
$2.60B
United States of America
AD
AD
Adeia Inc.
ADEA
|
US
$1.86B
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
$1.86B
United States of America
AD
AD
Aditxt, Inc.
ADTX
|
US
$1.83M
Acquires, develops, and deploys health technologies to address major health challenges.
$1.83M
United States of America
AD
AD
Advanced Biomed Inc.
ADVB
|
US
$13.90M
Develops microfluidic biochip diagnostic systems for precision oncology.
$13.90M
United States of America
AI
AI
AIM ImmunoTech Inc.
AIM
|
US
$4.25M
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
$4.25M
United States of America
AI
AI
Ainos, Inc.
AIMD
|
US
$12.31M
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
$12.31M
United States of America
AK
AK
Akero Therapeutics, Inc.
AKRO
|
US
$4.50B
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
$4.50B
United States of America
AL
AL
Aladdin Healthcare Technologies SE
NMI
|
DE
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
AL
AL
Alaunos Therapeutics, Inc.
TCRT
|
US
$7.50M
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
$7.50M
United States of America
AL
AL
Aligos Therapeutics, Inc.
ALGS
|
US
$64.74M
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
$64.74M
United States of America
AL
AL
Alpha Tau Medical Ltd.
DRTS
|
US
$430.58M
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
$430.58M
United States of America
AL
AL
Alteogen Inc.
196170
|
KR
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
AL
AL
AlzeCure Pharma
ALZCUR
|
SE
$25.44M
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
$25.44M
Sweden
AN
AN
ANAPTYSBIO, INC
ANAB
|
US
$1.42B
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
$1.42B
United States of America
AN
AN
AngioLab, Inc.
251280
|
KR
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
AN
AN
Anixa Biosciences Inc
ANIX
|
US
$105.33M
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
$105.33M
United States of America
AN
AN
Annovis Bio, Inc.
ANVS
|
US
$59.80M
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
$59.80M
United States of America
AP
AP
APPLIED DNA SCIENCES INC
APDN
|
US
$7.26M
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
$7.26M
United States of America
AP
AP
Aprea Therapeutics, Inc.
APRE
|
US
$5.87M
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
$5.87M
United States of America
AP
AP
AprilBio Co.,Ltd.
397030
|
KR
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
AP
AP
Aptahem AB
APTA
|
SE
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
AP
AP
APTAMER GROUP PLC
APTA
|
GB
$36.77M
Develops custom affinity binders for research, diagnostics, and therapeutics.
$36.77M
United Kingdom
AP
AP
Aptevo Therapeutics Inc.
APVO
|
US
$21.40M
Clinical-stage biotech developing antibody-based immunotherapies for cancer.
$21.40M
United States of America
AP
AP
APURES CO., LTD.
149300
|
KR
Biotech firm providing MICROPIG models, bio-resources, and non-clinical CRO services.
South Korea
AR
AR
Aran Research & Development (1982) Ltd.
ARAN
|
IL
$46.98M
A product design and development firm providing services from concept to manufacturing.
$46.98M
Israel
AR
AR
Artiva Biotherapeutics, Inc.
ARTV
|
US
$82.80M
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
$82.80M
United States of America
AR
AR
ARVINAS, INC.
ARVN
|
US
$860.45M
Clinical-stage biopharma developing therapeutics based on targeted protein degradation.
$860.45M
United States of America
AS
AS
Asarina Pharma AB
ASAP
|
SE
$67k
A biotechnology company in liquidation, formerly focused on neurosteroid therapies.
$67k
Sweden
AT
AT
Atara Biotherapeutics, Inc.
ATRA
|
US
$128.77M
Develops off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
$128.77M
United States of America
AT
AT
ATUM CO., LTD.
355690
|
KR
An integrated biologics development partner offering services from DNA sequence to cell bank.
South Korea
AV
AV
Avalo Therapeutics, Inc.
AVTX
|
US
$333.12M
Clinical-stage biotech developing treatments for immune-mediated inflammatory diseases.
$333.12M
United States of America
AZ
AZ
Azenta, Inc.
AZTA
|
US
$1.59B
Offers sample management, storage, and multiomics solutions for life sciences.
$1.59B
United States of America
BE
BE
BenevolentAI
BAI
|
GB
$13.08M
Applies artificial intelligence to accelerate drug discovery and development.
$13.08M
United Kingdom
BI
BI
bioAffinity Technologies, Inc.
BIAF
|
US
$5.53M
Develops noninvasive diagnostics and targeted therapeutics for cancer.
$5.53M
United States of America
BI
BI
BioArctic
BIOA
|
SE
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
Sweden
BI
BI
BioInfra Co.,Ltd.
199730
|
KR
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
BI
BI
BioInfra Life Science Inc.
266470
|
KR
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
BI
BI
BioNexus Gene Lab Corp
BGLC
|
US
$9.69M
Develops gene-based diagnostics for early detection of disease susceptibility.
$9.69M
United States of America
BI
BI
Biophytis S.A.
ALBPS
|
FR
$3.22M
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
$3.22M
France
BI
BI
BioRestorative Therapies, Inc.
BRTX
|
US
$10.30M
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
$10.30M
United States of America
Showing 1 to 50 of 405 companies